SAN FRANCISCO (MarketWatch) -- Dusa Pharmaceuticals Inc. shares leapt 35% to $3.75 in Thursday morning trade. The Wilmington, Mass.-based company announced that the Food and Drug Administration has ...
A conference call will be held today, Wednesday, October 22, 5:00 p.m. E.D.T. DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA) announced today results from its Phase IIB clinical trial to compare the ...
Aminolevulinic acid HCl 20%; topical soln; contains alcohol. Following the application of Levulan Kerastick topical solution, photosensitization occurs through the metabolic conversion of ...
PRESCOTT, Ariz. -- Firefighters "fight fire with fire" to stop spreading. Dermatologists have a similar technique - they "sunburn" patients to prevent precancerous skin lesions called actinic ...
About DUSA DUSA Pharmaceuticals, Inc. is a market leader in photodynamic therapy (PDT), marketing products to dermatologists to treat patients with minimally to moderately thick actinic keratoses (AKs ...
Oct 22 (Reuters) - Dusa Pharmaceuticals will stop developing its Levulan Photodynamic Therapy to treat moderate to severe acne, after the proposed treatment combination failed to show statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results